The elderly patient with low eGFR: beyond the numbers

Insights

Chronic Kidney Disease (CKD) affects many elderly individuals. This review highlights unique challenges in geriatric CKD care, advocating for personalized management plans and shared decision-making.

Area of Science:

  • Nephrology
  • Geriatrics
  • Public Health

Background:

  • Chronic Kidney Disease (CKD) is a significant health concern, particularly in the elderly population.
  • Existing clinical practice guidelines, such as KDIGO 2012, offer a framework for CKD management but may not fully address the specific needs of older adults.
  • Geriatric patients with CKD present unique physiological and comorbidity profiles.

Purpose of the Study:

  • To review the specific challenges and considerations in managing Chronic Kidney Disease in elderly patients.
  • To emphasize the need for individualized care approaches that go beyond general guidelines.
  • To promote shared decision-making in the management of geriatric CKD.

Main Methods:

  • This study is a review of current literature and clinical practice guidelines.
  • It synthesizes information on the unique aspects of CKD in older adults.
  • The review focuses on challenges and considerations for individualized patient care.

Main Results:

  • Elderly patients with CKD often have distinct characteristics requiring tailored management strategies.
  • General CKD guidelines may not adequately cover the complexities of geriatric kidney disease.
  • Individualized care plans are crucial for optimizing outcomes in this population.

Conclusions:

  • Management of Chronic Kidney Disease in the elderly necessitates a personalized approach.
  • Shared decision-making between clinicians and older patients is essential for effective CKD care.
  • Future strategies should focus on adapting guidelines for the unique needs of geriatric CKD patients.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
334
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
828
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
359
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
370
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
346